SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 140 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2018. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,000 | -93.8% | 18,340 | -3.6% | 0.00% | – |
| Q3 2018 | $32,000 | -3.0% | 19,020 | 0.0% | 0.00% | – |
| Q2 2018 | $33,000 | -2.9% | 19,020 | +2.8% | 0.00% | – |
| Q1 2018 | $34,000 | -17.1% | 18,500 | 0.0% | 0.00% | – |
| Q4 2017 | $41,000 | -19.6% | 18,500 | +5.5% | 0.00% | – |
| Q3 2017 | $51,000 | -38.6% | 17,530 | -5.9% | 0.00% | – |
| Q2 2017 | $83,000 | +10.7% | 18,630 | +15.1% | 0.00% | – |
| Q1 2017 | $75,000 | -2.6% | 16,190 | +28.2% | 0.00% | – |
| Q4 2016 | $77,000 | +10.0% | 12,630 | -0.8% | 0.00% | – |
| Q3 2016 | $70,000 | +59.1% | 12,730 | +10.7% | 0.00% | – |
| Q2 2016 | $44,000 | -35.3% | 11,500 | -30.7% | 0.00% | – |
| Q2 2014 | $68,000 | – | 16,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,009,984 | $16,683,000 | 6.50% |
| DAFNA Capital Management LLC | 317,563 | $2,636,000 | 2.23% |
| Trellus Management Company, LLC | 162,900 | $1,352,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 246,250 | $2,246,000 | 1.15% |
| WALL STREET ASSOCIATES | 861,200 | $7,148,000 | 0.67% |
| EAM Investors, LLC | 670,346 | $5,564,000 | 0.65% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 200,000 | $1,660,000 | 0.58% |
| CARL DOMINO INC | 66,900 | $555,000 | 0.38% |
| Belmont Global Advisors, Inc. | 36,200 | $300,000 | 0.33% |
| Lombard Odier Asset Management (USA) Corp | 507,223 | $4,210,000 | 0.30% |